Diethyl Aminomalonate Hydrochloride CAS 13433-00-6 Munditia ≥99.0% Favipiravir COVID-19

Description:

Nomen chemicum: Diethyl Aminomalonatum hydrochloridum

CAS: 13433-00-6

Aspectus: Alba vel Off-White Crystalline pulveris

Puritas: ≥99.0%

Medium Favipiravir (CAS: 259793-96-9) in curatione aegrorum COVID-19 commendatarum a WHO

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum Diethyl Aminomalonate Hydrochloride
Synonyma Aminomalonic Acidum Diethyl Ester hydrochloridum
CAS Number 13433-00-6
CATTUS Number RF-PI225
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C7H14ClNO4
M. Pondus 211.64
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba vel Off-White Crystalline pulveris
Liquescens punctum 162.0~ 168.0℃
Damnum in Siccatio ≤0.50%
Puritas ≥99.0%
una immunditia ≤0.50%
Totalis immunditias ≤1.0%
Test Standard Enterprise Standard
Consuetudinem Favipiravir (CAS, 259793-96-9)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

1

FAQ:

12

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabricae et supplementi Diethyl Aminomalonatis Hydrochloridis (CAS: 13433-00-6) cum qualitate, late in synthesi organica, synthesi intermediorum pharmaceuticae et synthesis pharmaceuticae activae.
Diethyl Aminomalonatus Hydrochloridis (CAS: 13433-00-6) adhibetur ut medium Favipiravir (CAS: 259793-96-9) in curatione aegri cum COVID-19 commendata a WHO.Favipiravir unus est e 5 mixtis commendatus ab QUI ad inquisitionem tractationis DE COVID-19.
Diethyl Aminomalonate hydrochloride in synthesi N (aminopropyl)-N-aroylaminopropyl substituto thiazolo[5,4-d] pyrimidinones et eius analogs ut kinesin fusi interdum inhibitores et potentiae agentium anticanorum.

Epistulam tuam hic scribe et mitte nobis